Frank Gary Romascavage, DO | |
Route 209, Brodheadsville, PA 18322 | |
(570) 992-5500 | |
Not Available |
Full Name | Frank Gary Romascavage |
---|---|
Gender | Male |
Speciality | General Practice |
Experience | 43 Years |
Location | Route 209, Brodheadsville, Pennsylvania |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1164535423 | NPI | - | NPPES |
R0182869 | Other | PA | PA BLUE SHIELD |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208D00000X | General Practice | OS004898L (Pennsylvania) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Kindred At Home | Stroudsburg, PA | Home health agency |
Comprehensive Medical Home Care | Dupont, PA | Home health agency |
Residential Healthcare Of Ne Pa, Llc | Kingston, PA | Home health agency |
Lehigh Valley Hospital - Pocono | East stroudsburg, PA | Hospital |
St Luke's Hospital - Monroe Campus | Stroudsburg, PA | Hospital |
Lehigh Valley Hospital | Allentown, PA | Hospital |
St Luke's Hospital Bethlehem | Bethlehem, PA | Hospital |
Mailing Address | Practice Location Address |
---|---|
Frank Gary Romascavage, DO Po Box 40, Route 209, Brodheadsville, PA 18322 Ph: (570) 992-5500 | Frank Gary Romascavage, DO Route 209, Brodheadsville, PA 18322 Ph: (570) 992-5500 |
News Archive
Prism Medical Ltd., a leading provider of durable medical equipment and related services to the mobility challenged, today reported financial results for the three months ended February 28, 2011.
A Monash University scientist has discovered key appetite control cells in the human brain degenerate over time, causing increased hunger and potentially weight-gain as we grow older.
Breast cancer is one of the most common cancers in the United States, striking 1 out of 8 women. About 80 percent of all breast cancers are estrogen receptor-positive, in which cancer growth is fueled by estrogen.
Bioniche Life Sciences Inc., a research-based, technology driven Canadian biopharmaceutical company, today announced that it has met the obligations associated with two milestones under its licensing agreement with Endo Pharmaceuticals for exclusive rights to develop and market Bioniche's proprietary product for non-muscle-invasive bladder cancer in North America.
Osiris Therapeutics, Inc., the leading stem cell company focused on developing and marketing products to treat medical conditions in the inflammatory, autoimmune, cardiovascular and orthopedic areas, announced today its results for the second quarter of fiscal 2010.
› Verified 6 days ago